Align Technology, Inc. vs Quantumscape Corp — how do they compare? Align Technology, Inc. trades at $179.9 (market cap $12.86B), while Quantumscape Corp trades at $6.49 (market cap $4.05B). The key difference: Align Technology, Inc. is far larger — about 3.2× Quantumscape Corp's market cap, and Align Technology, Inc. is trading nearer its 52-week high, Quantumscape Corp nearer its low. Which is the better fit depends on your goals.
| ALGN | QS | |
|---|---|---|
Market Cap | $12.86B | $4.05B |
Sector | Health | Consumer Cyclical |
52-Week High | $207.19 | $18.44 |
52-Week Low | $124.88 | $5.96 |
Enterprise Value | $11.92B | $3.21B |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
QuantumScape (QS) trades at $6.58, down 4.78% today, with a bearish technical outlook and negative profitability metrics. The company reported a net loss of $435.05 million in 2025, though cash flow improved to a net positive $85.27 million. Recent news highlights a joint research agreement with Honda, providing optimism for solid-state battery development. Analyst consensus is cautious, with 73% hold ratings and no buy recommendations.
The outlook remains speculative due to high cash burn and unproven commercialization. Risks include execution delays and EV market volatility. Upside depends on successful battery deployment, but near-term financial pressure and bearish sentiment suggest cautious investor positioning.
Trailing returns across standard periods
Latest headlines on both assets
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →